1-7 of 7
Matthew Wilson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 7149: The role of TROP2 in the MoA of Dato-DXd and how it underpins the biologic rationale of the novel AI-guided biomarker TROP2 normalized membrane ratio

Free
Matthew S. Sung, Matthew Wilson, Dominik Vonficht, Armin Meier, Chetan Rane, Charlie Dunlop, Gopi Patel, Anna Przybyla, Yann Wallez, Xiaochuan Liu, Ross Hill, James Harper, Markus Shick, Hadassah Sade, Danielle Carroll
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 7149.
https://doi.org/10.1158/1538-7445.AM2025-7149
Published: 21 April 2025
View article titled, Abstract 7149: The role of TROP2 in the MoA of Dato-DXd and how it underpins the biologic rationale of the novel AI-guided biomarker TROP2 normalized membrane ratio
Journal Articles

Abstract 2139: Identifying molecular mechanisms in triple negative breast cancer disparities: Unveiling the role of Hedgehog signaling in non-Hispanic Black women

Free
Jennifer Vanessa Cabezas, Savanna Touré, Matthew Wilson, Melody L. Stallings Mann, Laura M. Pacheco-Spann, Joshua W. Ogony, Mark E. Sherman, Derek C. Radisky
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2139.
https://doi.org/10.1158/1538-7445.AM2024-2139
Published: 22 March 2024
View article titled, Abstract 2139: Identifying molecular mechanisms in triple negative breast cancer disparities: Unveiling the role of Hedgehog signaling in non-Hispanic Black women
Journal Articles

Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a

Free
Rachel C. Brennan, Sara Federico, Cori Bradley, Jiakun Zhang, Jacqueline Flores-Otero, Matthew Wilson, Clinton Stewart, Fangyi Zhu, Kip Guy, Michael A. Dyer
Journal: Cancer Research
Cancer Res (2011) 71 (12): 4205–4213.
https://doi.org/10.1158/0008-5472.CAN-11-0058
Published: 14 June 2011
View article titled, Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a
Open the PDF for Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a in another window
Includes: Supplementary data
Journal Articles

Signals from the microenvironment induce a malignant program accompanied by de novo epigenetic remodeling

Free
Nancy Dumont, Yongping Crawford, Paul Reynolds, Matthew Wilson, Mahvash Sigaroudinia, Mona Gauthier, Colleen Fordyce, Thea Tlsty
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): LB-334.
Published: 01 May 2008
View article titled, Signals from the microenvironment induce a malignant program accompanied by de novo epigenetic remodeling
Journal Articles

Tumor suppressor p16INK4a regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells.

Free
Paul Reynolds, Mahvash Sigaroudinia, Giuseppe Zardo, Matthew Wilson, Geoffrey Benton, Joseph Costello, Thea Tlsty
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4143.
Published: 01 May 2007
View article titled, Tumor suppressor p16INK4a regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells.
Journal Articles

Neuronal Differentiation and Synaptogenesis in Retinoblastoma

Free
Dianna A. Johnson, Jiakun Zhang, Sharon Frase, Matthew Wilson, Carlos Rodriguez-Galindo, Michael A. Dyer
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2701–2711.
https://doi.org/10.1158/0008-5472.CAN-06-3754
Published: 15 March 2007
View article titled, Neuronal Differentiation and Synaptogenesis in Retinoblastoma
Open the PDF for Neuronal Differentiation and Synaptogenesis in Retinoblastoma in another window
Includes: Supplementary data
Journal Articles

Inhibition of growth of human breast cancer cell lines with the combination of an mTOR inhibitor and a Bcl-2 inhibitor

Free
Matthew Wilson, Lois Witters, Heidi Lane, Allan Lipton
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 519.
Published: 15 April 2006
View article titled, Inhibition of growth of human breast cancer cell lines with the combination of an mTOR inhibitor and a Bcl-2 inhibitor